Sign in

CIK 0001599298 · Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
371979717
Phone
305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
  1. 4 Derivatives Options or other derivatives
  2. 4 Option exercise Co-Chief Executive Officer acquired 315,681 shares (option exercise)
  3. 4 Grant or award Co-Chief Executive Officer acquired 44,052 shares (grant or award)
  4. 4 Grant or award Co-Chief Executive Officer acquired 3,325,991 shares (grant or award)
  5. 4 Grant or award Director acquired 44,052 shares (grant or award)
  6. 4 Grant or award COO and CFO acquired 44,052 shares (grant or award)
  7. 4 Grant or award Chief Accounting Officer acquired 22,026 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Chief Executive Officer bought 110,321 shares at an average $3.73 ($411,094)
  18. 4 Open-market buy Chief Financial Officer bought 100,000 shares at $3.75 ($375,000)
  19. 5 Insider Annual Insider Trading Report
  20. 4 Derivatives Options or other derivatives

Page 3 of 7 · 130 filings